SOX4 Transcriptionally Regulates Multiple SEMA3/Plexin Family Members and Promotes Tumor Growth in Pancreatic Cancer

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Huang, Hsin Yi ^a,b   Cheng, Yu Yao ^b   Liao, Wei Chih ^b   Tien, Yu Wen ^b   Yang, Chih Hsin James ^b   Hsu, Su Ming ^a,b,c   Huang, Pei Hsin ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 129 2; MICRORNA 335; PLEXIN; SEMAPHORIN; SEMAPHORIN 3A; SEMAPHORIN 3B; SEMAPHORIN 3C; SEMAPHORIN 3E; SEMAPHORIN 3F; TRANSCRIPTION FACTOR SOX4; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PANCREAS ADENOCARCINOMA; PLXN GENE; PROMOTER REGION; PROTEIN DEGRADATION; RNA INTERFERENCE; SEMA3 GENE; SOX4 GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR PROMOTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NERVE TISSUE PROTEINS; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; RECEPTORS, CELL SURFACE; SEMAPHORINS; SOXC TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

MUS;

EID: 84871192281     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048637     Document Type: Article

References (53)

1. Kim EJ, Simeone DM, (2011) Advances in pancreatic cancer. Curr Opin Gastroenterol 27: 460-406.
2. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
3. Gaur P, Bielenberg DR, Samuel S, Bose D, Zhou Y, et al. (2009) Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis. Clin Cancer Res 15: 6763-6770.
4. Neufeld G, Kessler O, (2008) The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer 8: 632-45.
5. Müller MW, Giese NA, Swiercz JM, Ceyhan GO, Esposito I, et al. (2007) Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer. Int J Cancer 121: 2421-2433.
6. Tseng C-H, Murray KD, Jou M-F, Hsu S-M, Cheng H-J, et al. (2011) Sema3E/Plexin-D1 mediated epithelial-to-mesenchymal transition in ovarian endometrioid cancer. PLoS ONE 6: e19396.
7. Liao Y-H, Hsu S-M, Huang P-H, (2007) ARMS depletion facilitates UV irradiation-induced apoptotic cell death in melanoma. Cancer Res 67: 11547-11556.
8. Hatziapostolou M, Iliopoulos D, (2011) Epigenetic aberrations during oncogenesis. Cell Mol Life Sci 68: 1681-1702.
9. Kusy S, Potiron V, Zeng C, Franklin W, Brambilla E, et al. (2005) Promoter characterization of semaphorin SEMA3F, a tumor suppressor gene. Biochim Biophys Acta- Gene Structure and Expression 1730: 66-76.
10. Jiang SX, Sheldrick M, Desbois A, Slinn J, Hou ST, (2007) Neuropilin-1 is a direct target of the transcription factor E2F1 during cerebral iIschemia-induced neuronal death in vivo. Mol Cell Biol 27: 1696-1705.
11. Kodo K, Nishizawa T, Furutani M, Arai S, Yamamura E, et al. (2009) GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling. Proc Natl Acad Sci U S A 106: 13933-13938.
12. Liao YL, Sun YM, Chau GY, Chau YP, Lai TC, et al. (2008) Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma. Oncogene 27: 5578-5589.
13. Aaboe M, Birkenkamp-Demtroder K, Wiuf C, Sørensen FB, Thykjaer T, et al. (2006) SOX4 expression in bladder carcinoma: clinical aspects and In vitro functional characterization. Cancer Res 66: 3434-3442.
14. Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML, et al. (2009) Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res 69: 709-717.
15. Tao Y, Kassatly RF, Cress WD, Horowitz JM, (1997) Subunit composition determines E2F DNA-binding site specificity. Mol Cellr Biol 17: 6994-7007.
16. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, et al. (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53: 549-554.
17. Huang YW, Liu JC, Deatherage DE, Luo J, Mutch DG, et al. (2009) Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res 69: 9038-46.
18. Shen R, Pan S, Qi S, Lin X, Cheng S, (2010) Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer. Biochem Biophys Res Commun 394: 1047-1052.
19. Zhang S, Kim K, Jin UH, Pfent C, Cao H, et al. (2012) Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells. Mol Cancer Ther 11: 108-118.
20. Chedotal A, Kerjan G, Moreau-Fauvarque C, (2005) The brain within the tumor: new roles for axon guidance molecules in cancers. Cell Death Differ 12: 1044-1056.
21. Bielenberg D, Klagsbrun M, (2007) Targeting endothelial and tumor cells with semaphorins. Cancer Metastasis Rev 26: 421-431.
22. Roth L, Koncina E, Satkauskas S, Crémel G, Aunis D, et al. (2009) The many faces of semaphorins: from development to pathology. Cell Mol Life Sci 66: 649-666.
23. Stratton MR, Campbell PJ, Futreal PA, (2009) The cancer genome. Nature 458: 719-724.
24. van der Weyden L, Adams DJ, Harris LW, Tannahill D, Arends MJ, et al. (2005) Null and conditional semaphorin 3B alleles using a flexible puroDeltatk loxP/FRT vector. Genesis 41: 171-8.
25. Liu ET, (2008) Functional genomics of cancer. Curr Opin Genet Dev 18: 251-256.
26. Schilham MW, Oosterwegel MA, Moerer P, Ya J, de Boer PAJ, et al. (1996) Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature 380: 711-714.
27. Schilham MW, Moerer P, Cumano A, Clevers HC, (1997) Sox-4 facilitates thymocyte differentiation. Eur J Immunol 27: 1292-1295.
28. Sekiya I, Vuoristo JT, Larson BL, Prockop DJ, (2002) In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci U S A 99: 4397-4402.
29. Nissen-Meyer LSH, Jemtland R, Gautvik VT, Pedersen ME, Paro R, et al. (2007) Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice. J Cell Sci 120: 2785-2795.
30. Bergsland M, Werme M, Malewicz M, Perlmann T, Muhr J, (2006) The establishment of neuronal properties is controlled by Sox4 and Sox11. Genes Dev 20: 3475-3486.
31. Kim H-D, Choe HK, Chung S, Kim M, Seong JY, et al. (2011) Class-C SOX transcription factors control GnRH gene expression via the intronic transcriptional enhancer. Mol Endocrinol 25: 1184-1196.
32. Potzner MR, Tsarovina K, Binder E, Penzo-Méndez A, Lefebvre V, et al. (2010) Sequential requirement of Sox4 and Sox11 during development of the sympathetic nervous system. Development 137: 775-84.
33. Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K, et al. (2009) Autocrine TGF-β signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 5: 504-514.
34. Lin B, Madan A, Yoon J-G, Fang X, Yan X, et al. (2010) Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma. PLoS ONE 5: e10210.
35. de Bont JM, Kros JM, Passier MMCJ, Reddingius RE, Smitt PAES, et al. (2008) Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro Oncol 10: 648-660.
36. Jafarnejad SM, Wani AA, Martinka M, Li G, (2010) Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion. Am J Pathol 177: 2741-2752.
37. Sinner D, Kordich JJ, Spence JR, Opoka R, Rankin S, et al. (2007) Sox17 and Sox4 differentially regulate β-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol Cell Biol 27: 7802-7815.
38. Frierson Jr HF, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, et al. (2002) Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 161: 1315-1323.
39. Medina PP, Castillo SD, Blanco S, Sanz-Garcia M, Largo C, et al. (2009) The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer. Hum Mol Genet 18: 1343-1352.
40. Castillo SD, Matheu A, Mariani N, Carretero J, Lopez-Rios F, et al. (2012) Novel transcriptional targets of the SRY-HMG box transcription factor SOX4 link its expression to the development of small cell lung cancer. Cancer Res 72: 176-186.
41. Lioubinski O, Müller M, Wegner M, Sander M, (2003) Expression of Sox transcription factors in the developing mouse pancreas. Dev Dyn 227: 402-408.
42. Bhattaram P, Penzo-Mendez A, Sock E, Colmenares C, Kaneko KJ, et al. (2010) Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors. Nat Commun 1: 9.
43. Ahn S-G, Kim H-S, Jeong S-W, Kim B-E, Rhim H, et al. (2002) Sox-4 is a positive regulator of Hep3B and HepG2 cells' apoptosis induced by prostaglandin (PG)A(2) and delta(12)-PGJ(2). Exp Mol Med 34: 243-249.
44. Hur EH, Hur W, Choi JY, Kim IK, Kim HY, et al. (2004) Functional identification of the pro-apoptotic effector domain in human Sox4. Biochem Biophysical Res Commun 325: 59-67.
45. Moreno CS, (2010) The Sex-Determining Region Y-Box 4 and Homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways. Am J Pathol 176: 518-527.
46. Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K, Miyazono K, (2009) Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 5: 504-514.
47. Heidenblad M, Lindgren D, Jonson T, Liedberg F, Veerla S, et al. (2008) Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors. BMC Medical Genomics 1: 3.
48. Baumgart M, Heinmöller E, Horstmann O, Becker H, Ghadimi BM, (2005) The genetic basis of sporadic pancreatic cancer. Cell Oncol 27: 3-13.
49. Fu B, Luo M, Lakkur S, Lucito R, Iacobuzio-Donahue CA, (2008) Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma. Cancer Biol Ther 7: 1593-1601.
50. Tavazoie SF, Alarcon C, Oskarsson T, Paudua D, Wang Q, Bos PD, et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
51. Dyrskjøt L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, et al. (2009) Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69: 4851-4860.
52. Tsai K-W, Wu C-W, Hu L-Y, Li S-C, Liao Y-L, et al. (2011) Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Int J Cancer 129: 2600-2610.
53. Sato N, Maitra A, Fukushima N, van Heek NT, Matsubayashi H, et al. (2003) Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 63: 4158-4166.